|
|
Jielin Zhang, David T. Scadden, Clyde S. Crumpacker
J Clin Invest. 2007;
117(2):473
doi:10.1172/JCI28971
Abstract |
Full text
| PDF
| Supplemental material
H
ematopoietic stem cells are resistant to HIV-1 infection. Here, we report a novel mechanism by which the cyclin-dependent kinase inhibitor (CKI) p21Waf1/Cip1/Sdi1 (p21), a known regulator of stem cell pool size, restricts HIV-1 infection of primitive hematopoietic cells. Modifying p21 expression altered HIV-1 infection prior to changes in cell cycling and was selective for p21 since silencing the related CKIs, p27Kip1 and p18INK4C, had no effect on HIV-1. We show that p21 blocked viral infection by complexing with HIV-1 integrase and aborting chromosomal integration. A closely related lentivirus with a distinct integrase, SIVmac-251, and the other cell-intrinsic inhibitors of HIV-1, Trim5α, PML, Murr1, and IFN-α, were unaffected by p21. Therefore, p21 is an endogenous cellular component in stem cells that provides a unique molecular barrier to HIV-1 infection and may explain how these cells remain an uninfected “sanctuary” in HIV disease.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(29)
| Title and authors |
Publication |
Year |
Definition, Natural History and Heterogeneity of HIV Controllers
Asier Sáez-Cirión, Gianfranco Pancino, Olivier Lambotte
|
Models of Protection Against HIV/SIV
|
2012 |
HIV-1 and the macrophage
Sebastiaan M Bol, Viviana Cobos-Jiménez, Neeltje A Kootstra, Angélique B van ’t Wout
|
Future Virology
|
2011 |
Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon.
Thomas Pertel, Christian Reinhard, Jeremy Luban
|
Retrovirology
|
2011 |
CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21
Huabiao Chen, Chun Li, Jinghe Huang, Thai Cung, Katherine Seiss, Jill Beamon, Mary F. Carrington, Lindsay C. Porter, Patrick S. Burke, Yue Yang, Bethany J. Ryan, Ruiwu Liu, Robert H. Weiss, Florencia Pereyra, William D. Cress, Abraham L. Brass, Eric S. Rosenberg, Bruce D. Walker, Xu G. Yu, Mathias Lichterfeld
|
J. Clin. Invest.
|
2011 |
HIV-1 Utilizes the CXCR4 Chemokine Receptor to Infect Multipotent Hematopoietic Stem and Progenitor Cells
Christoph C. Carter, Lucy A. McNamara, Adewunmi Onafuwa-Nuga, Mark Shackleton, James Riddell, Dale Bixby, Michael R. Savona, Sean J. Morrison, Kathleen L. Collins
|
Cell Host & Microbe
|
2011 |
Effects of HIV-1 gp120 and Protease Inhibitors on Apoptotic Susceptibility of CD34+ Hematopoietic Progenitor Cells
Owen J MacEneaney, Elizabeth Connick, Christopher A DeSouza
|
JAIDS Journal of Acquired Immune Deficiency Syndromes
|
2011 |
The TRIM Family Protein KAP1 Inhibits HIV-1 Integration
Awatef Allouch, Cristina Di Primio, Emanuele Alpi, Marina Lusic, Daniele Arosio, Mauro Giacca, Anna Cereseto
|
Cell Host & Microbe
|
2011 |
Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers
A. Saez-Cirion, C. Hamimi, A. Bergamaschi, A. David, P. Versmisse, A. Melard, F. Boufassa, F. Barre-Sinoussi, O. Lambotte, C. Rouzioux, G. Pancino
|
Blood
|
2011 |
The Ongoing Challenge of Hematopoietic Stem Cell-Based Gene Therapy for β-Thalassemia
Ekati Drakopoulou, Eleni Papanikolaou, Nicholas P. Anagnou
|
Stem Cells International
|
2011 |
A whole genome screen for HIV restriction factors
Li Liu, Nidia MM Oliveira, Kelly M Cheney, Corinna Pade, Hanna Dreja, Ann-Marie H Bergin, Viola Borgdorff, David H Beach, Cleo L Bishop, Matthias T Dittmar
|
Retrovirology
|
2011 |
|